HR 863
116th Congress
House
Health
Child health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Licensing and registrations
Prescription drugs
Retail and wholesale trades
DXM Abuse Prevention Act of 2019
Introduced: January 30, 2019
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 30, 2019
Referred to the House Committee on Energy and Commerce.
Jan 30, 2019
Introduced in House
Plain-English summary
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1
Cosponsors
1